Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.

Article  PubMed  Google Scholar 

Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249–57.

Article  PubMed  PubMed Central  Google Scholar 

Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity. 2007;15:2817–24.

Article  PubMed  Google Scholar 

Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB. Clinical and Patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to roux-en-Y gastric bypass surgery versus intensive lifestyle management: the SLIMM-T2D study. Diabetes Care. 2018;41:670–9.

Article  PubMed  PubMed Central  Google Scholar 

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.

Article  PubMed  Google Scholar 

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376:641–51.

Article  PubMed  PubMed Central  Google Scholar 

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36.

Article  PubMed  Google Scholar 

Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379:2300–11.

Article  PubMed  Google Scholar 

Yoshino M, Kayser BD, Yoshino J, Stein RI, Reeds D, Eagon JC, et al. Effects of diet versus gastric bypass on metabolic function in diabetes. N Engl J Med. 2020;383:721–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M, et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell Function in type 2 diabetic patients. Diabetes. 2013;62:3027–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids. J Clin Endocrinol Metab. 2015;100:E1225–33.

Article  PubMed  PubMed Central  Google Scholar 

Wewer Albrechtsen NJ, Geyer PE, Doll S, Treit PV, Bojsen-Moller KN, Martinussen C, et al. Plasma proteome profiling reveals dynamics of inflammatory and lipid homeostasis markers after Roux-En-Y gastric bypass surgery. Cell Syst. 2018;7:601–12.e3.

Article  CAS  PubMed  Google Scholar 

Dreyfuss JM, Yuchi Y, Dong X, Efthymiou V, Pan H, Simonson DC, et al. High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control. Nat Commun. 2021;12:6951.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrera A, von Toerne C, Behler J, Huth C, Thorand B, Hilgendorff A, et al. Multiplatform approach for plasma proteomics: complementarity of olink proximity extension assay technology to mass spectrometry-based protein profiling. J Proteome Res. 2021;20:751–62.

Article  CAS  PubMed  Google Scholar 

Shah RV, Hwang SJ, Yeri A, Tanriverdi K, Pico AR, Yao C, et al. Proteins altered by surgical weight loss highlight biomarkers of insulin resistance in the community. Arter Thromb Vasc Biol. 2019;39:107–15.

Article  CAS  Google Scholar 

Katz DH, Robbins JM, Deng S, Tahir UA, Bick AG, Pampana A, et al. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci Adv. 2022;8:eabm5164.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Hanash S. Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells. Methods. 2015;81:34–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Wang C, Zhu S, Zhang P, Liang H. Chinese surgical guidelines for obesity and type 2 diabetes (2019). Chin J Pract Surg. 2019;39:301–6.

Google Scholar 

Yang W, Wang C. Metabolic surgery needs stronger endorsement in Asian T2DM patients with low BMI. Obes Surg. 2022;32:212–3.

Article  PubMed  Google Scholar 

Diaz-Canestro C, Chen J, Liu Y, Han H, Wang Y, Honore E, et al. A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes. Cell Rep Med. 2023;4:100944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones JM, Morrell JC, Gould SJ. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem. 2000;275:12590–7.

Article  CAS  PubMed  Google Scholar 

Howard TA, Misra DN, Grove M, Becich MJ, Shao JS, Gordon M, et al. Human gastric intrinsic factor expression is not restricted to parietal cells. J Anat. 1996;189:303–13.

PubMed  PubMed Central  Google Scholar 

Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600.

Article  CAS  PubMed  Google Scholar 

Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arter Thromb Vasc Biol. 2001;21:542–7.

Article  CAS  Google Scholar 

Slunt HH, Thinakaran G, Von Koch C, Lo AC, Tanzi RE, Sisodia SS. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem. 1994;269:2637–44.

Article  CAS  PubMed  Google Scholar 

Inagaki T, Dutchak P, Zhao GX, Ding XS, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPAR alpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415–25.

Article  CAS  PubMed  Google Scholar 

Jin L, Lin Z, Xu A. Fibroblast growth factor 21 protects against atherosclerosis via fine-tuning the multiorgan crosstalk. Diabetes Metab J. 2016;40:22–31.

Article  PubMed  PubMed Central  Google Scholar 

Enyindah-Asonye G, Li Y, Ruth JH, Spassov DS, Hebron KE, Zijlstra A, et al. CD318 is a ligand for CD6. Proc Natl Acad Sci USA. 2017;114:E6912–E6921.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardoso MS, Santos RF, Almeida S, Sa M, Perez-Cabezas B, Oliveira L, et al. Physical interactions with bacteria and protozoan parasites establish the scavenger receptor SSC4D as a broad-spectrum pattern recognition receptor. Front Immunol. 2021;12:760770.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu L, Zhu Y, Watari K, Lee M, Liu J, Perez S, et al. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness. Cell Metab. 2023;35:1009–1021.e9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diaz-Canestro C, Xu A. Impact of different adipose depots on cardiovascular disease. J Cardiovasc Pharmacol. 2021;78:S30–S39.

Article  CAS  PubMed